Literature DB >> 6178804

Neuritogenic determinant of bovine P2 protein in peripheral nerve myelin.

K Uyemura, M Suzuki, K Kitamura, K Horie, Y Ogawa, H Matsuyama, S Nozaki, I Muramatsu.   

Abstract

Experimental allergic neuritis (EAN) is an experimentally produced demyelinating disease of peripheral nervous system. Several peptides of bovine P2 protein were tested for neuritogenic activity in Lewis rats. The hexacosapeptide CiT4 (residues 53--78 of bovine P2 protein) showed the highest neuritogenic activity among the peptides tested. The nonapeptide (residues 70--78) and the tridecapeptide (residues 66--78) were synthesized using the liquid phase peptide synthesis technique. The tridecapeptide showed mild, but definite activity in inducing EAN in the rats, while the nonapeptide was inactive. The localization of the neuritogenic determinant of bovine P2 protein in Lewis rats is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6178804     DOI: 10.1111/j.1471-4159.1982.tb07979.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

1.  Comparative study of experimental autoimmune neuritis in SJL mice and Lewis rats.

Authors:  A Rostami
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

2.  T lymphocyte autoimmunity in peripheral nervous system autoimmune disease.

Authors:  C Linington; H Wekerle; R Meyermann
Journal:  Agents Actions       Date:  1986-12

3.  P2-peptide induced experimental allergic neuritis: a model to study axonal degeneration.

Authors:  A F Hahn; T E Feasby; L Wilkie; D Lovgren
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

4.  Lipid binding activities of the P2 protein in peripheral nerve myelin.

Authors:  K Uyemura; K Yoshimura; M Suzuki; K Kitamura
Journal:  Neurochem Res       Date:  1984-10       Impact factor: 3.996

5.  Degradation of bovine P2 protein by bovine brain cathepsin D.

Authors:  J N Whitaker; J M Seyer
Journal:  Neurochem Res       Date:  1984-10       Impact factor: 3.996

6.  Structural and functional characterization of human peripheral nervous system myelin protein P2.

Authors:  Viivi Majava; Eugenia Polverini; Alberto Mazzini; Rahul Nanekar; Wiebke Knoll; Judith Peters; Francesca Natali; Peter Baumgärtel; Inari Kursula; Petri Kursula
Journal:  PLoS One       Date:  2010-04-22       Impact factor: 3.240

7.  Antibodies to gliomedin cause peripheral demyelinating neuropathy and the dismantling of the nodes of Ranvier.

Authors:  Jérôme J Devaux
Journal:  Am J Pathol       Date:  2012-08-10       Impact factor: 4.307

8.  Immunohistochemical localization of S-100 protein and peripheral nerve myelin proteins (P2 protein, P0 protein) in granular cell tumors.

Authors:  M Mukai
Journal:  Am J Pathol       Date:  1983-08       Impact factor: 4.307

9.  Neurofascin as a target for autoantibodies in peripheral neuropathies.

Authors:  Judy King Man Ng; Joachim Malotka; Naoto Kawakami; Tobias Derfuss; Mohsen Khademi; Tomas Olsson; Christopher Linington; Masaaki Odaka; Björn Tackenberg; Harald Prüss; Jan M Schwab; Lutz Harms; Hendrik Harms; Claudia Sommer; Matthew N Rasband; Yael Eshed-Eisenbach; Elior Peles; Reinhard Hohlfeld; Nobuhiro Yuki; Klaus Dornmair; Edgar Meinl
Journal:  Neurology       Date:  2012-10-24       Impact factor: 9.910

10.  Lipid content of swine influenza and other vaccines.

Authors:  K C Leskawa; E L Hogan; S Dasgupta; J L Chien; R E Erwin; S W Brostoff
Journal:  Lipids       Date:  1986-05       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.